# An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

> **NCT00644332** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 172 (actual)

## Conditions studied

- Chronic Angina

## Interventions

- **DRUG:** Ranolazine

## Key facts

- **NCT ID:** NCT00644332
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644332, "An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00644332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*